Epithelial-to-mesenchytnal transition and stem cells in endometrial cancer


Por: Mirantes, C, Espinosa, I, Ferrer, I, Dolcet, X, Prat, J, Matias-Guiu, X

Publicada: 1 oct 2013
Resumen:
This review article describes the main features of epithelial-to-mesenchymal transition (EMT) and its possible role in understanding myometrial invasion in endometrial carcinoma (EC), as well as the development of malignant mixed Mullerian tumor (MMMT). Moreover, the article discusses the possible role of somatic (SSC) and cancer stem cells (CSC) in EC. Different transcriptional repressors of E-cadherin have been identified in EMT, including Snail and Slug, ZEB1 and ZEB2, and E47 and Twist. The expression of some of these genes is increased at the myoinvasive front and correlates inversely with E-cadherin inmunoreactivity. Whereas the transient occurrence of the EMT phenomenon is important for myometrial invasion in conventional EC, MMMT shows permanent expression of EMT leading to repression of E-cadherin and increased expression of mesenchymal markers including proteins involved in skeletal muscle development. An SSC population, identified as a side population, assessed by the Hoechst dye exclusion test has been identified in human endometrium. CSCs have been defined in analogy to SSC as cancer cells that have the capacity to self-renew, which means undergoing divisions that allow the generation of more identical CSCs and give rise to the variety of more differentiated cells found in the malignancy. Although published data show that CD133(+) cells retain the characteristics of CSC, there is no conclusive evidence showing that CD133 is the universal marker for EC stem cells. Finally, a possible role for endometrial stem cells in the development of ovarian endometriosis and ovarian endometrioid carcinoma is commented. (C) 2013 Elsevier Inc. All rights reserved.

Filiaciones:
Mirantes, C:
 Univ Lleida, Hosp Univ Arnau de Vilanova, Dept Pathol & Mol Genet, IRBLLEIDA, Lleida 25198, Spain

 Univ Lleida, Hosp Univ Arnau de Vilanova, Res Lab, IRBLLEIDA, Lleida 25198, Spain

Espinosa, I:
 Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Pathol, Barcelona 08026, Spain

Ferrer, I:
 Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Pathol, Barcelona 08026, Spain

Dolcet, X:
 Univ Lleida, Hosp Univ Arnau de Vilanova, Dept Pathol & Mol Genet, IRBLLEIDA, Lleida 25198, Spain

 Univ Lleida, Hosp Univ Arnau de Vilanova, Res Lab, IRBLLEIDA, Lleida 25198, Spain

Prat, J:
 Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Pathol, Barcelona 08026, Spain

Matias-Guiu, X:
 Univ Lleida, Hosp Univ Arnau de Vilanova, Dept Pathol & Mol Genet, IRBLLEIDA, Lleida 25198, Spain

 Univ Lleida, Hosp Univ Arnau de Vilanova, Res Lab, IRBLLEIDA, Lleida 25198, Spain
ISSN: 00468177





HUMAN PATHOLOGY
Editorial
W B SAUNDERS CO-ELSEVIER INC, 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 44 Número: 10
Páginas: 1973-1981
WOS Id: 000325037000002
ID de PubMed: 23845467

MÉTRICAS